Last reviewed · How we verify
NCT04487717: PREDICT
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
trial testing nProfiler I Stomach Cancer Assay Kit in Gastric Cancer in 581 participants. Participants enrolled and being followed up; not accepting new ones.
31 October 2029
Quick facts
| Lead sponsor | Novomics. Co., Ltd. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 581 |
| Start date | 29 July 2020 |
| Primary completion | 31 October 2029 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- nProfiler I Stomach Cancer Assay Kit
Conditions studied
- Gastric Cancer — all drugs for Gastric Cancer →
Sponsor
Novomics. Co., Ltd.
Who can join
19 and older, any sex, with Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective assessment of nProfiler® 1 predictive test on prognosis and chemotherapy response for resectable gastric cancer
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Current Evidence and Future Direction of Adjuvant Treatment for Gastric Cancer in the Era of Precision Medicine.
Yun JH, Choi YY, Cheong JH. · · 2025 · cited 4× · PMID 39901705 · DOI 10.4143/crt.2024.1222 -
Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts.
Choi YY, Jang E, Kim H, Kim KM, et al · · 2021 · cited 4× · PMID 34815632 · DOI 10.21147/j.issn.1000-9604.2021.05.05
Verify or expand the search:
- PubMed search for NCT04487717
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of nProfiler I Stomach Cancer Assay Kit
Trials testing the same drug.
- NCT04600518 — Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer · completed
- NCT06521528 — A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test · active not recruiting
- NCT03403296 — A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemothe · completed
Other recruiting trials for Gastric Cancer
Currently open trials in the same condition.
- NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
- NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
- NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting
Other Novomics. Co., Ltd. trials
Trials by the same sponsor.
- NCT04600518 — Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer · completed
- NCT06521528 — A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04487717 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novomics. Co., Ltd.
- Last refreshed: 17 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04487717.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing